Regulating the economic evaluation of pharmaceuticals and medical devices: a European perspective
Authors:
- Richard CooksonRCRichard Cookson
- John HuttonJHJohn Hutton
- 1 February 2003
- journal article
- Published by Elsevier in Health Policy
- Vol. 63 (2) , 167-178
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- "NICE" in Germany?HEPAC Health Economics in Prevention and Care, 2000
- Review of European guidelines for economic evaluation of medical technologies and pharmaceuticalsHEPAC Health Economics in Prevention and Care, 2000
- Current Trends in the Use of Pharmacoeconomics and Outcomes Research in EuropeValue in Health, 1999
- Pharmacoeconomics in European decision-making.Value in Health, 1999
- Pharmacoeconomic Evaluation in the Real WorldPharmacoEconomics, 1999
- The elderly, medicines and robust evidence from randomised control trialsJournal of Clinical Effectiveness, 1998
- Modelling in Ecomomic Evaluation: An Unavoidable Fact of LifeHealth Economics, 1997
- Why we need observational studies to evaluate the effectiveness of health careBMJ, 1996
- Some guidelines on the use of cost effectiveness league tables.BMJ, 1993
- Explanatory and pragmatic attitudes in therapeutical trialsJournal of Chronic Diseases, 1967